Overview
Jemma Arakelyan practices practicing medicine in Hong Kong, China.
Her clinical expertise encompasses Pancreatic Islet Cell Tumor and Hodgkin Lymphoma.
She is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jemma Arakelyan
Is Jemma Arakelyan a top-rated expert for Pancreatic Islet Cell Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Jemma Arakelyan is classified as an Experienced expert for Pancreatic Islet Cell Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jemma Arakelyan participate in research or clinical trials?
Yes. Jemma Arakelyan has published 20 articles and abstracts on conditions like Pancreatic Islet Cell Tumor. You can view a list of Jemma Arakelyan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hodgkin LymphomaMs. Arakelyan isExperienced. Learn about Hodgkin Lymphoma.
- Pancreatic Islet Cell TumorMs. Arakelyan isExperienced. Learn about Pancreatic Islet Cell Tumor.